Gather-ed - Addressing the Challenges in Alzheimer's Disease Diagnosis and Management

Target Professions:	DO, MD, Nurse, Nurse Practitioner, Physician Assistant, Veterinarian
Target Specialties:	Neurology, Geriatrics, Family Medicine, Internal Medicine, Long-Term Care, Radiology, Psychiatry, Other, Dementia
Credits Available:	3.25 AMA PRA Category 1 Credit™, Maintenance of Certification (MOC) points available

Alzheimer’s disease (AD) is the leading cause of cognitive impairment and dementia in older individuals (≥ 65 years) throughout the world. In the United States (U.S.), more than 6 million individuals carry this diagnosis, with many yet to be diagnosed. AD follows a prolonged, progressive disease course that begins with pathophysiological changes years before any clinical manifestations are observed. Individuals harboring such changes may have no symptoms or may exhibit clinical manifestations varying from memory lapses to severe and debilitating loss of memory and cognitive function. There are several clinical gaps including the use of biomarkers in AD diagnosis, knowledge of new and emerging disease-modifying treatments, and multidisciplinary care coordination in early AD. Through an interactive educational initiative bringing together AD experts and clinicians involved in AD care, we aim to educate all those involved to improve the care of patients with early AD.

CME/CE Accreditation Information

Itinerary

Part One - Baseline Assessment, Self Study, Live Group Discussion 1, Final Assessment

Addressing the Challenges in Alzheimer's Disease Diagnosis and Management - Baseline Assessment

The following questions are designed to assess your knowledge and practice of patients with Alzheimer's disease.

Module 1: Early Alzheimer’s Disease Diagnosis and Multidisciplinary Care

This module will cover the diagnosis and early recognition of Alzheimer’s disease (AD) and mild cognitive impairment (MCI).

Module 2: Biomarkers in AD Diagnosis

This module will cover the current and future use of biomarkers in AD diagnosis and management.

Module 3: Disease-modifying Therapies in MCI and Early AD

The focus of this module will be on monoclonal antibodies emerging and approved for use in treating early AD.

Addressing the Challenges in Alzheimer's Disease Diagnosis and Management - Final Assessment

The following questions are designed to assess your knowledge and practice of patients with Alzheimer's disease.

Key Insights on Alzheimer's Disease and Take-Home Messages: Putting the Evidence to Practice

During this discussion, we will review the modules and approaches to treatment that offer optimal care to patients with Alzheimer's disease.

Part Two - Group Challenge, Action Plan, Live Group Discussion 2

Case Challenge - David, a 72-year-old man

Meet David, a 72-year-old man who presents with memory problems and difficulty performing daily tasks.

Your action plan in: Alzheimer's Disease

In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the diagnosis and management for your patients with Alzheimer's Disease.

Patient Case Review: Discussing Treatment and Care for Patients with Alzheimer's Disease

During this discussion, we will review the patient case and discuss treatment plans. Additionally, we will share our action plans and how this CME activity will shape our practice regarding patient care.